Get started
Author

Fernando Magro

IOlBD evidence-based consensus on the use of artificial intelligence for assessment of endoscopic and histologic endpoints in clinical trials of inflammatory bowel disease
2026 · Axel Dignass, Neeraj Narula, et al. · Journal of Crohn s and Colitis · 2
Integrated metabolomics and genetic analyses reveal loss of protective docosahexaenoic acid as a key driver linking ultra-processed food to Crohn’s disease risk
2026 · Sidan Wang, Lintao Dan, et al. · medRxiv · 1
Integrated Metabolomic and Genetic Profiling Implicates Loss of Docosahexaenoic Acid in the Link Between Ultraprocessed Foods and Crohn’s Disease
2026 · Sidan Wang, Lintao Dan, et al. · Clinical Gastroenterology and Hepatology
Mirikizumab treatment decreases ulcerative colitis-related surgery and hospitalisation rates: 4-year LUCENT studies results
2026 · F Magro, A Ananthakrishnan, et al. · Zeitschrift für Gastroenterologie
P1119 Mirikizumab treatment decreases Ulcerative Colitis-related surgery and hospitalisation rates: 4-year LUCENT studies Results
2026 · F Magro, A Ananthakrishnan, et al. · Journal of Crohn s and Colitis
PDF
DOP047 Circulating metabolites unveil a link between ultra-processed food and the development of Inflammatory Bowel Disease: a multi-cohort study among Western and Eastern populations
2026 · S Wang, L Dan, et al. · Journal of Crohn s and Colitis
PDF
P1108 Upadacitinib improves histologic and endoscopic-histologic outcomes in the colon and ileum of patients with moderately to severely active Crohn’s disease
2026 · F Magro, V Jairath, et al. · Journal of Crohn s and Colitis
PDF
OP14 Risk of Inflammatory Bowel Disease Following Hospital-Treated Infections and Modulatory Role of Host Genetics to support a multi-hit pathogenesis model
2026 · H Zhuang, L Dan, et al. · Journal of Crohn s and Colitis
P0980 Association of endoscopic, histologic, and composite outcomes with long-term guselkumab efficacy in ulcerative colitis: 2-year results from the QUASAR long-term extension
2026 · F Magro, D T Rubin, et al. · Journal of Crohn s and Colitis
P0016 Exploring DPP4 in intestinal inflammation: a cross-matrix approach using the TNBS-induced model of colitis
2026 · S F Gomes, M Ferreira-Duarte, et al. · Journal of Crohn s and Colitis
P1233 Mediterranean dietary approaches to stop hypertension intervention for neurodegenerative delay (MIND) diet is associated with reduced inflammatory bowel disease-related surgery risk
2026 · Y Sun, L Dan, et al. · Journal of Crohn s and Colitis
P1284 Systematic evaluation of the modulation of environmental and genetic susceptibility to the development of inflammatory bowel disease by socioeconomic status
2026 · F Jing, L Dan, et al. · Journal of Crohn s and Colitis
P1234 The role of alcohol consumption in the incidence of inflammatory bowel disease depends on acetaldehyde metabolism burden
2026 · J Chen, Y Guo, et al. · Journal of Crohn s and Colitis
P1156 Association Between Histologic and Endoscopic Outcomes With Long-Term Clinical and Symptomatic Outcomes in Patients With Moderately to Severely Active Ulcerative Colitis Treated With Upadacitinib
2026 · F Magro, V Jairath, et al. · Journal of Crohn s and Colitis
PDF
Works count: 14
Citation count: 3
H-index: 1
I10-index:
Year
Topic
Type